Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 16:12:651038.
doi: 10.3389/fphar.2021.651038. eCollection 2021.

Adenosine Metabotropic Receptors in Chronic Pain Management

Livio Luongo  1   2 , Francesca Guida  1 , Sabatino Maione  1   2 , Kenneth A Jacobson  3 , Daniela Salvemini  4
Affiliations

Adenosine Metabotropic Receptors in Chronic Pain Management

Livio Luongo et al. Front Pharmacol. .
No abstract available

Keywords: A1AR; A2AR; A3AR; metabotropic adenosine receptors; neuropathic pain; new targets.

PubMed Disclaimer

Conflict of interest statement

DS is founder of BioIntervene, Inc., a company developing A3AR agonists for clinical use. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The figure illustrates the several A3AR agonists use in different preclinical model of neuropathic pain of various origins.
See this image and copyright information in PMC

References

    1. Bai H. H., Liu J. P., Yang L., Zhao J. Y., Suo Z. W., Yang X., Hu X. D. (2017). Adenosine A1 receptor potentiated glycinergic transmission in spinal cord dorsal horn of rats after peripheral inflammation. Neuropharmacology 126, 158–167. 10.1016/j.neuropharm.2017.09.001 - DOI - PubMed
    1. Bar-Yehuda S, Luger D, Ochaion A, Cohen S, Patokaa R, Zozulya G, et al. (2011). Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101. Int. J. Mol. Med. 28 (5), 727–31. 10.3892/ijmm.2011.753 - DOI - PMC - PubMed
    1. Bura A. S., Nadal X., Ledent C., Maldonado R., Valverde O. (2008). A2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury. Pain 140 (1), 95–103. 10.1016/j.pain.2008.07.012 - DOI - PubMed
    1. Cekic C, Linden J. (2016). Purinergic regulation of the immune system. Nat. Rev. Immunol. 16, 177–192. 10.1038/nri.2016.4 - DOI - PubMed
    1. Chen Z., Janes K., Chen C., Doyle T., Bryant L., Tosh D. K., et al. (2012). Controlling murine and rat chronic pain through A 3 adenosine receptor activation. FASEB J. 26 (5), 1855–1865. 10.1096/fj.11-201541 - DOI - PMC - PubMed

LinkOut - more resources